Synlait Milk Cuts Loss 81% and Opens the Door to New Customers After Asset Sale
Synlait unveils ‘Stabilise, Simplify, Scale’ recovery roadmap alongside HY26 results
Synlait Milk has reported disappointing half-year financial results whilst simultaneously outlining a clear three-stage recovery strategy designed to reposition the dairy processor for long-term success. The Synlait Milk HY26 Recovery Roadmap arrives as the company prepares to complete the sale of its North Island assets next week, a transaction management frames as a fundamental balance sheet reset. The company’s forecast FY26 milk price stands at $9.90/kgMS (total average payment to farmers), whilst the renewed executive team is now based in Dunsandel.
Total group EBITDA reached $64.4M, representing an 88% increase on HY25, whilst operating cash flow improved dramatically to $85.4M compared to negative $80.6M in the prior corresponding period. Total group revenue came in at $949.0M. However, the company reported a total underlying group NPAT loss of $34.7M, an improvement from the $183.4M loss in HY25. Net debt stood at $472.1M, down from $643.4M at FY25.
Richard Wyeth, CEO
“Building commercial optionality into our future is critical.”
The North Island asset sale represents the pivotal event enabling the recovery roadmap. For investors assessing the company’s restructuring trajectory, this transaction removes loss-making assets whilst creating capacity for new customer opportunities that were previously on hold.
When big ASX news breaks, our subscribers know first
What drove HY26’s challenging result
Chair George Adams and CEO Richard Wyeth explicitly stated they would not “dress things up” when explaining the half-year outcome. The result reflects what management characterised as a “perfect storm” of five sequential challenges, rather than operational incompetence.
The series began with an inventory shortfall stemming from FY25 manufacturing challenges, which required catch-up production. Synlait adjusted its manufacturing plan to enable teams to focus on rebuilding customer inventory. This revised plan resulted in surplus milk, particularly during peak season, which the company attempted to sell tactically.
When a number of the milk sales did not materialise as planned, Synlait’s Dunsandel teams were forced to pause catch-up production to process the unsold milk. Due to dryer configurations at the facility, whole milk powder (WMP) became the only viable product. Global WMP prices then decreased sharply at the end of calendar 2025, resulting in significant Ingredients portfolio losses.
An insurance claim is expected to recover a portion of the FY25 manufacturing losses, though the amount remains undisclosed. The company has also taken a conservative approach to deferred tax asset recognition, limiting recognition to unused tax losses beyond those recorded at 31 July 2025.
For investors evaluating management credibility, this framing is significant. The result reflects severely constrained commercial options rather than execution failures.
Progress on ‘Our Big 6’ strategic priorities
Despite headline losses, Synlait has executed across six strategic priorities established for FY26. Leadership appointments include Chief Operating Officer Rich Hickson (joined February 2026), who brings operational transformation experience and infant formula expertise. Chief Quality Officer Hila Mory has delivered a new Quality Strategy and launched the Synlait Care initiative, resulting in measurable uplift across core quality metrics. Enhanced ARA testing has been implemented, though this is extending release times and impacting working capital.
Chief Revenue Officer Hamish Yates (joined December 2025) has reset Synlait’s Revenue Strategy, shifting from key account management to a customer-centric business culture. The closure of Synlait’s Palmerston North facility is estimated to save over $2M annually. The renewed executive leadership team is now Canterbury-based, with a new People, Culture and Safety Strategy delivering a more robust performance framework.
The Big 6 priorities and progress:
- Operational Stability: New COO Rich Hickson appointed; talent pool deepening underway
- Quality Performance: New Quality Strategy implemented; measurable uplift in core metrics; Synlait Care launched
- Strengthening Culture: Renewed ELT in place; new People, Culture and Safety Strategy deployed
- Customer Satisfaction: New CRO Hamish Yates appointed; Revenue Strategy reset completed
- Financial Resilience: Close collaboration with banking syndicate; North Island sale to strengthen balance sheet
- Financial Performance: Palmerston North closure delivering >$2M annual savings; cost reduction focus maintained
Understanding dairy processor recovery dynamics
Dairy processors face unique operational constraints that limit strategic flexibility during periods of stress. Milk is perishable and must be processed immediately, meaning surplus milk forces commodity production regardless of market conditions. Dryer configurations at processing facilities often limit product flexibility, with certain dryers capable of producing only specific outputs such as WMP. Global commodity prices can swing rapidly, exposing processors without contracted volumes to significant margin compression.
This context explains why Synlait’s result was genuinely constrained rather than simply mismanaged. The lack of “commercial optionality” referenced repeatedly by leadership refers directly to these structural limitations within dairy processing operations.
Customer relationships and future growth optionality
Synlait’s relationship with The a2 Milk Company is transitioning, with English-label a2 Platinum® production moving to a2’s Pōkeno facility. Synlait retains production of the China-label 至初 product, which is registered to be manufactured at the company’s Dunsandel facility. This transition frees manufacturing capacity that creates new global customer opportunities previously on hold.
The company has agreed a third party manufacture (TPM) agreement with Abbott for base powder production following completion of the North Island asset sale. CFO Andy Liu has worked closely with Synlait’s banking syndicate to manage cashflow challenges during the half.
Capacity freed by the a2 transition and North Island sale creates revenue diversification potential. This is the “optionality” thread running through the entire Synlait Milk HY26 Recovery Roadmap, representing the strategic foundation for medium-term growth.
Balance sheet reset and financial outlook
FY26 guidance has been withdrawn, with the Board confirming no full-year guidance will be provided for the remainder of the financial year. The North Island sale is expected to strengthen the balance sheet materially, though specific debt reduction targets have not been disclosed. The insurance claim outcome remains pending.
| Metric | HY26 | HY25 Comparison |
|---|---|---|
| Group EBITDA | $64.4M | +88% |
| Operating cash flow | $85.4M | vs -$80.6M |
| Underlying NPAT | -$34.7M | vs -$183.4M |
| Net debt | $472.1M | Down $171.3M from FY25 |
The next major ASX story will hit our subscribers first
Roadmap to recovery: what comes next
The Synlait Milk HY26 Recovery Roadmap centres on three interconnected horizons. Stabilise focuses on delivering operational stability that meets customer expectations, strengthens financial resilience, and builds greater optionality. Simplify aims to align priorities, sharpen capability, and grow high-margin products from existing assets to lift profitability. Scale targets expansion across markets, channels, and customers whilst executing future growth opportunities.
George Adams, Chair
“Behind our roadmap to recovery sits a real determination to ensure the coming 12 to 24 months will be seen as a period where Synlait under promised and over delivered.”
Management has committed that further growth opportunities will only be considered when the company is confident Synlait is well-positioned to fund and deliver them. The explicit prioritisation of stability over expansion signals disciplined capital allocation, a positive for investors concerned about prior overextension. The renewed, Canterbury-based executive leadership team will focus on building additional commercial optionality and maximising returns from existing assets before pursuing new growth initiatives.
Don’t Miss the Next Consumer Staples Recovery Play
Join 20,000+ investors receiving FREE breaking ASX news delivered within minutes of release, complete with in-depth analysis. Get market-moving announcements from Consumer Staples and every major ASX sector the moment they hit the market. Click the “Free Alerts” button at Big News Blast to start receiving real-time alerts ahead of the crowd.